InsiderSignalSign in

← Insider buys

Michael Halstead bought stock once, on Sep 21, 2026

Chief Executive Officer at CYBIN INC., and 1 other company

SEC CIK 0001521548 · Filings on SEC.gov ↗

$1.3MBought

$30.7MSold

Sep 21Last buy

Michael Halstead's record

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Companies

Every filing

26 filings since Jan 2017, newest first

CYBIN INC.

Chief Executive Officer

$1.3M+145.8%Sep 21

Intra-Cellular Therapies, Inc.

President

$3.7M−100.0%Nov 14

Intra-Cellular Therapies, Inc.

EVP and General Counsel

$1.4M−100.0%Mar 11

Intra-Cellular Therapies, Inc.

EVP and General Counsel

$550K−100.0%Feb 27

Intra-Cellular Therapies, Inc.

EVP and General Counsel

$788K−100.0%Feb 5

Intra-Cellular Therapies, Inc.

EVP and General Counsel

$3.3M−100.0%Jan 12

Intra-Cellular Therapies, Inc.

EVP and General Counsel

$1.1M−100.0%Mar 13

Intra-Cellular Therapies, Inc.

EVP and General Counsel

$372K−100.0%Feb 27

Intra-Cellular Therapies, Inc.

EVP and General Counsel

$522K−100.0%Feb 22

Intra-Cellular Therapies, Inc.

EVP and General Counsel

$2.7M−100.0%Dec 2

Intra-Cellular Therapies, Inc.

EVP and General Counsel

$411K−100.0%Feb 25

Intra-Cellular Therapies, Inc.

EVP and General Counsel

$617K−100.0%Feb 23

Intra-Cellular Therapies, Inc.

EVP and General Counsel

$801K−100.0%Jan 11

Intra-Cellular Therapies, Inc.

EVP and General Counsel

$8.4M−100.0%Dec 23

Intra-Cellular Therapies, Inc.

EVP and General Counsel

$437K−100.0%Feb 22

Intra-Cellular Therapies, Inc.

EVP and General Counsel

$629K−100.0%Jan 12

Intra-Cellular Therapies, Inc.

EVP and General Counsel

$506K−100.0%Jan 5

Intra-Cellular Therapies, Inc.

EVP and General Counsel

$2.2M−100.0%Nov 19

Intra-Cellular Therapies, Inc.

EVP and General Counsel

$514K−99.0%Jan 10

Intra-Cellular Therapies, Inc.

EVP and General Counsel

$651K−52.0%Jan 8

Intra-Cellular Therapies, Inc.

EVP and General Counsel

$253K−27.0%Jan 3

Intra-Cellular Therapies, Inc.

EVP and General Counsel

$284K−99.0%Jan 8

Intra-Cellular Therapies, Inc.

EVP and General Counsel

$87K−27.0%Jan 3

Intra-Cellular Therapies, Inc.

SVP and General Counsel

$460K−99.0%Jan 24

Intra-Cellular Therapies, Inc.

SVP and General Counsel

$69K−14.0%Jan 5

Intra-Cellular Therapies, Inc.

SVP and General Counsel

$26K−7.0%Jan 9

Filings come from SEC EDGAR. Not investment advice.